Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.

MLA

Li, Rongzhen, et al. “Neoadjuvant Chemotherapy and Radiotherapy Followed by Resection/Ablation in Stage IV Rectal Cancer Patients with Potentially Resectable Metastases.” BMC Cancer, vol. 21, no. 1, Dec. 2021, p. 1333. EBSCOhost, https://doi.org/10.1186/s12885-021-09089-5.

APA

Li, R., Wang, Q., Zhang, B., Yuan, Y., Xie, W., Huang, X., Zhou, C., Zhang, S., Niu, S., Chang, H., Chen, D., Miao, H., Zeng, Z. F., Xiao, W., & Gao, Y. (2021). Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases. BMC Cancer, 21(1), 1333. https://doi.org/10.1186/s12885-021-09089-5

Chicago

Li, Rongzhen, Qiaoxuan Wang, Bin Zhang, Yan Yuan, Weihao Xie, Xiaoxue Huang, Chengjing Zhou, et al. 2021. “Neoadjuvant Chemotherapy and Radiotherapy Followed by Resection/Ablation in Stage IV Rectal Cancer Patients with Potentially Resectable Metastases.” BMC Cancer 21 (1): 1333. doi:10.1186/s12885-021-09089-5.